Nine furoquinoline alkaloids (1-9) were isolated from the leaves of Evodia lepta based on bioassay-guided fractionation and chromatographic techniques. All isolates were evaluated for their cholinesterase (ChEs) inhibitory activities, in which kokusaginine (7) and melineurine (5) exhibited the highest activity toward AChE and BChE, respectively. Lineweaver-Burk plots indicated that 5 and 7 were mixed mode inhibitors of both ChE enzymes. Molecular docking studies on the binding sites of AChE and BChE were performed in order to afford a molecular insight into the mode of action of these active compounds. From this study these compounds have emerged as promising molecules for Alzheimer's disease therapy.
Alzheimer's disease (AD) is the most common cause of neurodegenerative disorder and dementia in elderly people. Based on the cholinergic hypothesis, which proposes that AD is caused by reduced synthesis of the neurotransmitter acetylcholine (ACh) in the brain, a promising approach for the treatment of AD is to enhance ACh levels by using inhibitors of acetylcholinesterase (AChE), the selective enzyme responsible for the hydrolysis of ACh at the cholinergic synapses [1, 2] . In addition, a substrate nonspecific butyrylcholinesterase (BChE) is also found to play a significant role in the hydrolysis of ACh. Moreover, there are several reports that have revealed that the reduction of AChE activity can be compensated for by BChE activity [3] . Thus, all of the above reasons have stimulated a great interest in screening natural cholinesterase (ChE) inhibitors as lead compounds for the intended treatment of AD as they should have significant inhibition activities towards both AChE and BChE.
Previous reports have shown that some furoquinoline alkaloids and other constituents of Rutaceae species have ChE activities relevant to the treatment of AD [4, 5] . Therefore, the extraction and isolation of bioactive ChE inhibiting compounds from the plants of this family have been interesting, as they can themselves be active and used directly as a drug. Evodia lepta (Spreng.) Merr. (Rutaceae) is a traditional medicinal plant used for the treatment of arthritis, fever, chickenpox, influenza, meningitis, infectious hepatitis, and antipruritic, depurative and febrifuge diseases [6, 7] . Several furoquinoline alkaloids, flavonoids and chromones have also been reported from this plant in previous studies [8] [9] [10] .
This study further investigated the ChE inhibiting constituents from E. lepta with nine furoquinoline alkaloids being isolated from the leaves, some of which showed potent ChE inhibitory activities. The active CH 2 Cl 2 extract was initially fractionated by vacuum column chromatography eluting with increasing polarity using CH 2 Cl 2 , EtOAc and MeOH to afford six major fractions (A-F). Fractions B and E were further purified using a combination of silica gel column chromatography and radial chromatography (chromatotron), [9] , melineurine (5) [10] , skimmianine (6) , kokusaginine (7) [5] , heliparvifoline (8) [11] and 7-hydroxydictamnine (9) [8] . The structures of all isolated compounds were established by NMR spectroscopic and MS data, all of which were in good comparison with those from the literature.
Determination of the ChE inhibitory activities of all furoquinoline alkaloids from the leaves of E. lepta was carried out using an assay modified from the spectroscopic method of Ellman [12, 13] . The ChE inhibition activities of all isolated alkaloids, at a concentration of 100 μg/mL, are shown in Table 1 . As can be seen, compound 7 displayed good inhibition (81.4%) of AChE, and the other eight compounds (1-6, 8 and 9) showed only moderate AChE inhibition (33.8-69.9%). In contrast, compounds 5 and 9 exhibited a significant inhibition of BChE (91.8% and 85.0%, respectively), while the other compounds (1-4 and 6-8) showed only moderate BChE inhibition (41.0-61.9%).
Quantitative analysis to determine the concentration of compounds that inhibited by more than 50% (4-7) was necessary to decrease the AChE enzyme activity by 50% (IC 50 ) and was performed using a microplate method. In this in vitro assay, kokusaginine (7) possessed the most anti-AChE activity with an IC 50 value of 28.2 μM (Table 1) .
On the other hand, compounds 1, 2, 5 and 6-9 also inhibited BChE activity in a dose-dependent manner. The concentrations required for IC 50 were determined to be 28.0-99.4 μM, with melineurine (5) possessing the highest anti-BChE activity, with an IC 50 value of 28.0 μM (Table 1) .
To gain an insight into the mode of AChE inhibition by the furoquinoline alkaloids, kokusaginine (7) was further used as a model for kinetic studies. The Lineweaver-Burk plots of 7 gave a series of straight lines, all of which intersect in the second quadrant ( Figure 2 ). The analysis demonstrated the increasing K m value (the negative reciprocal of the X-intercept) and the deceasing V max value (the reciprocal of the Y-intercept). These kinetic results indicate a reversible and mixed inhibition at the active site of AChE. In addition, the mechanism of melineurine (5) was studied in depth in vitro. The kinetic analysis of BChE inhibition of 5 is shown in Figure 3 . The K m and V max values were calculated from the Lineweaver-Burk plot. The V max value of BChE, as plotted against [BTCI], increased significantly with the addition of 5, while the V max value decreased. These results indicated that 5 inhibited BChE in a mixed competitive manner.
In order to evaluate the activity of furoquinoline alkaloids against AChE and BChE, molecular docking calculations were employed. The pose which showed lowest binding free energy, of each compound, was selected for further analysis. Compound 7 exhibited the most potent activity against AChE with an IC 50 value of 28.2 μM and compound 5 showed activity against BChE with an IC 50 value of 28.0 μM. Figure 4A shows the pose of 7 bound with AChE. The molecular docking calculation showed a binding free energy of -6.00 kcal/mol. We found that the furano ring pointed towards Tyr334 (PAS site) and formed a CH … π interaction between the H and centroid of Tyr334, with a distance of 2.8 Å. The methoxy group, which was attached to the furanoquinoline moiety, was lying on the hydrophobic pocket of Trp84 (anionic site) and Phe330. Moreover, the two methoxy groups, which are substituents on the aromatic ring, displayed hydrogen bonding (H-bond) with the amino acid residues Gly119, Ser200 and His440, which are part of the catalytic site, at distances of 2.56, 2.77 and 3.15 Å, respectively.
Compound 5 was the most active against BChE. It showed a binding free energy when binding to BChE of -5.83 kcal/mol. The oxygen atom in the linker can form a H-bond with Tyr128 at a distance of 2.74 Å and the nitrogen atom of the furanoquinoline ring displayed an H-bond with the NH (backbone) of Gly121 at a distance of 3.02 Å, as can be found in Figure 4B . Interestingly, the 3,3-dimethyl-2-propeneyloxyl group was placed in close proximity to and electrostatically interacted with the COOof Glu197. This interaction is due to 3,3-dimethyl-2-propeneyloxyl withdrawing electron density from the 3,3-dimethyl moiety, resulting in a positively partial charged hydrogen atom. Therefore, the oxygen atom of the Glu197 sidechain formed H-bonds at distances of 2.88 and 3.38 Å. The methoxy group substituted on the furanoquinoline moiety displayed an H-bond with Asp70 with a distance of 3.19 Å. Moreover, the 3,3-dimethyl moiety docked deep into the catalytic pocket and formed a hydrophobic interaction with Ser198, His438, and Ile 442 in the catalytic site.
The effect of changing the substitution at the R 1 , R 2 and R 3 positions was also studied. For AChE, compound 6 (IC 50 69.1 μM) was chosen for a comparison with the most potent compound (7) . R 1 , which is a methoxy group and R 3 , which is H, on 7, have been modified to H and a methoxy group, respectively on 6. We found that R 3 (-OCH 3 ) of 6 formed a slight H-bond with Gly119 with a distance of 3.12 Å and the R 2 (-OCH 3 ) pointed toward Ser200 and formed a partial H-bond with His440, with distances of 3.00 and 3.07 Å, respectively, as shown in Figure 5A . It seems that this compound interacted with crucial amino acid residues, but with longer distances compared with those with 7. This results in the rotation of the molecular plane and loss of the CH π  interaction with Tyr334 and the methoxy group on the furanoquinoline moiety losing its hydrophobic interaction with Trp84 and Phe330.
It was of particular interest to study the effect of changing the substituent at the R 2 position. Even though the only difference with 4 is that it has a methoxy group at R 2 , the percentage of inhibitory activity against BChE is 2.2 fold lower in comparison with 5. Figure S5 shows all of the calculated binding affinities of 200 predicted conformations. The lowest binding free energy of each compound was selected for molecular interaction analyses, see Supporting Information. We found that the methoxy group at R 2 on 4 cannot form a H-bond with Tyr128 (3.60 Å), as depicted in Figure  5B . Indeed, it undergoes steric hindrance with Tyr128, and, therefore, the molecular plane was shifted behind, and the 3,3dimethyl-2-propeneyloxyl was inserted deep into the pocket, causing loss of the H-bond with Glu197.
For the AChE enzyme, compound 5 (IC 50 value of 95.3 M) showed an activity lower than 7 (most active with IC 50 value of 28.2 M). We found that 5 showed a binding free energy of -5.56 kcal/mol. The bulky 3,3-dimethyl-2-propeneyloxyl substituent was placed in the narrow pocket of E199, S200 and H440, which caused steric repulsion with those amino acid residues. Therefore, the molecular plane was shifted with the loss of H-bond interactions with E199, S200 and the CH π  interaction with Y334 (see Figure  S6 (A) in Supporting Information).
In the case of BChE, compound 7 (inactive with IC 50 higher than 100 M) was selected for comparison with 5 (most active with IC 50 value of 28.0 M). The docking result showed that 7 has a binding free energy of -5.00 kcal/mol and cannot form strong H-bonds with E197 and S198, and forms a weak H-bond with Y128 (3.02 Å) (see Figure S6 (B) in Supporting Information). This is due to the two methoxy group substituents at the R 1 and R 2 positions of 7, which have shorter side chains than the 3,3-dimethyl-2-propeneyloxyl substituent of 5. These methoxy groups of 7 are placed far away from the crucial amino acids E197 and S198, with a distance longer than 5 Å, resulting in the loss of the H-bond interactions.
The molecular docking calculations of 7 and 5 were in a good agreement with the bioactivity assay against cholinesterase. Compound 7 was able to inhibit AChE with the lower IC 50 value, compared with BChE. The two methoxy group substituents on the aromatic ring of 7 play an important role for interacting with AChE through H-bonds. The 3,3-dimethyl-2-propeneyloxyl substituent of 5 was occupied and interacted with BChE through H-bonds and hydrophobic interactions.
In conclusion, we succeeded in identifying that 5 and 7 are responsible for the anti-ChEs in E. lepta leaves. The kinetic analysis indicated that 5 and 7 inhibited both ChEs in mixed competitive manners. Finally, the molecular docking calculations of 5 and 7 were in a good agreement with their anti-ChE results. Therefore, this information can help in designing a new inhibitor in the class of furoquinoline alkaloids against Alzheimer's disease.
Experimental
General: 1D and 2D NMR spectra were recorded on a Bruker 400 AVANCE spectrometer, and the chemical shifts were reported in parts per million (ppm); TMS was used as the internal standard. Melting points were determined on a Fisher-Johns Melting Point apparatus. Adsorbents such as silica gel 60 (Merck) were used for column chromatography and radial chromatography (chromatotron model 7924T, Harrison Research). Merck silica gel 60F 254 plates were used for TLC. HRESIMS were obtained using a Bruker MICROTOF model mass spectrometer. UV-visible absorption spectra were taken on a UV-2550 (SHIMADZU) UV-Vis spectrometer (Shimadzu, Kyoto, Japan). 
Enzymes and reagents:

Extraction and isolation:
Air-dried and finely powdered leaves (1 kg) of E. lepta were sequentially extracted at room temperature for 6 days with MeOH (2 × 5 L). The MeOH extract was suspended in water and partitioned with CH 2 Cl 2 . The CH 2 Cl 2 extract was fractionated by silica gel vacuum column chromatography (VCC) using mixtures of EtOAc-n-hexane (5:95, 25:75, 50:50 and 60:40 v/v) and EtOAc, yielding 6 major fractions (A-F). Fraction B was subjected to silica gel column chromatography (CC) eluting with 100% CH 2 Cl 2 to give 5 sub-fractions (B1-B5). Sub-fraction B2 was purified by radial chromatography (chromatotron) using 100% CH 2 Cl 2 to obtain 1 (20.3 mg), 2 (12.4 mg) and 4 (8.9 mg). Subfraction B3 was purified by radial chromatography using CH 2 Cl 2 -EtOAc (1:0-0:1, v/v) to afford 3 (19.8 mg) and 5 (9.4 mg). Finally, sub-fraction B4 was subjected to silica gel CC eluting with CH 2 Cl 2 and EtOAc gradient systems to afford 6 (13.3 mg). In addition, fraction E was loaded onto an open silica gel column to obtain 5 major fractions (E1-E5). Sub-fraction E3 was separated by CC over silica gel using 20%, 50% and 100% EtOAc-n-hexane as the eluent to yield 7 (14.8 mg) and 8 (1.5 mg). Finally, sub-fraction E5 was selected for purification using a chromatotron eluting with EtOAcn-hexane (70:30, v/v) to give 9 (4.5 mg). The chemical structures of these compounds were determined using various spectroscopic methods (1D and 2D NMR, IR, UV) and MS (see Supporting Information for details).
Cholinesterase inhibitory (anti-ChE) assay:
Stock solutions of the test compounds (1-9) and the reference anti-ChE compound (eserine) were prepared in 50 mM Tris-HCl, pH 8.0, containing 1362 Natural Product Communications Vol. 10 (8) 2015 Sichaem et al.
≤ 10% (v/v) methanol. The AChE and BChE inhibitory activity assays and the kinetic studies were performed using a modification of Ellman's colorimetric method [12] .
Molecular docking Method of calculation protein and inhibitor preparation for docking calculations:
Compounds 5 and 7 were modeled and geometry optimized at B3LYP/6-31G* level of theory by using the Gaussian09 program [13] . The protein AChE (PDB code: 1EVE) [14] and BChE (PDB code: 4BDS) [15] were retrieved from RCSB Protein Data Bank [Research Collaboratory for Structural Bioinformatics (http://www.rcsb.org/ pdb)]. The hydrogen atoms and all missing atoms were then added to the proteins. Subsequently, the protonation state of ionizable amino acid residues was predicted at pH 7.0 using the Discovery Studio 2.0 software (Website, www.accelrys.com). The proteins were then subjected to further molecular docking study.
Molecular docking calculation:
Recently, molecular docking calculations have become important and useful tools for gaining insight into the mode of action and important interactions between inhibitors and enzyme [16] . In this work, we performed molecular docking calculations of furoquinoline alkaloid derivatives by using the AutoDock4.2 program [17] . The binding pocket of AChE composed of the catalytic triads, anionic site, and oxyanionic hole, including the PAS, were taken as the binding site for docking study [14] . The binding site in BChE was defined as of the Tacrine molecule [15] .
The parameter as grid size (grid space of 0.375 Å) of 50 x 50 x 50 was defined for AChE and 60 x 60 x 60 for BChE. The number of runs was defined as 200 and the Lamagian GA algorithm was employed while the other parameters were set as default.
